Inhibition/activation in bipolar disorder: Validation of the Multidimensional Assessment of Thymic States scale (MAThyS)

BMC Psychiatry

Volumn 13, Issue , 2013, Pages

  Henry, Chantal ^a   Luquiens, Amandine ^b   Lançon, Christophe ^c,d   Sapin, Hélène ^e   Zins Ritter, Marcel ^f   Gerard, Stephanie ^e   Perrin, Elena ^e   Falissard, Bruno ^b,g   Lukasiewicz, Michael ^b,g  

^a FACULTÉ DE MÉDECINE   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c TIMONE HOSPITAL   (France)

^d HÔPITAL SAINTE MARGUERITE   (France)

^e ELI LILLY AND COMPANY   (United States)

^f Private practice ^*  (France)

^g INSERM   (France)

Author keywords

Bipolar disorder; Clinical trial; Emotional reactivity; Factorial analysis; Olanzapine; Scale

Indexed keywords

FLUOXETINE PLUS OLANZAPINE; LITHIUM; OLANZAPINE; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR DISORDER; DEPRESSION; EFFECT SIZE; FACTORIAL ANALYSIS; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; MANIA; MULTIDIMENSIONAL ASSESSMENT OF THYMIC STATES SCALE; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRINCIPAL COMPONENT ANALYSIS; PSYCHOLOGIC ASSESSMENT; PSYCHOMETRY; RATING SCALE; VALIDATION PROCESS; YOUNG MANIA RATING SCALE;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DEPRESSION; FACTOR ANALYSIS, STATISTICAL; HUMANS; MALE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 84874796778     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-13-79     Document Type: Article

References (11)

1. Hantouche EG, Akiskal HS, Azorin JM, Châtenet-Duchêne L, Lancrenon S. Clinical and psychometric characterization of depression in mixed mania: a report from the french national cohort of 1090 manic patients. J Affect Disord 2006, 96:225-232. 10.1016/j.jad.2005.01.005, 16427703.
2. Benazzi F, Koukopoulos A, Akiskal HS. Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression). Eur Psychiatry 2004, 19:85-90. 10.1016/j.eurpsy.2003.09.008, 15051107.
3. Ghaemi SN, Rosenquist KJ, Ko JY, Baldassano CF, Kontos NJ, Baldessarini RJ. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry 2004, 161:163-165. 10.1176/appi.ajp.161.1.163, 14702267.
4. Rihmer Z, Akiskal H. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. J Affect Disord 2006, 94:3-13. 10.1016/j.jad.2006.04.003, 16712945.
5. Henry C, M'Bailara K, Mathieu F, Poinsot R, Falissard B. Construction and validation of a dimensional scale exploring mood disorders: MAThyS (Multidimensional Assessment of Thymic States). BMC Psychiatry 2008, 8:82. 10.1186/1471-244X-8-82, 2561027, 18803831.
6. Henry C, M'Baïlara K, Poinsot R, Casteret AA, Sorbara F, Leboyer M, Vieta E. Evidence for two types of bipolar depression using a dimensional approach. Psychother Psychosom 2007, 76:325-331. 10.1159/000107559, 17917467.
7. Henry C, Luquiens A, Lançon C. Activation/Inhibition Response, Efficacy, Safety of Olanzapine in Acute Bipolar Patient: Secondary Outcomes of a 24-Weeks Open-Label Single-Arm Trial 2010, New Orleans, LA: 163rd APA annual meeting, Abstract NR1-49.
8. Akiskal HS, Hantouche EG, Bourgeois ML, Azorin JM, Sechter D, Allilaire JF, Chatenêt-Duchêne L, Lancrenon S. Toward a refined phenomenology of mania: combining clinician-assessment and self-report in the French EPIMAN study. J Affect Disord 2001, 67:89-96. 10.1016/S0165-0327(01)00441-4, 11869755.
9. Henry C, Luquiens A, Lançon C. Validation de l'échelle " Multidimensional assessment of THYmic states" (Etude MAThyS). LEncéphale 2010, 36(Issue 1, Supplement 1):56-57.
10. Staquet MJ, Hays RD, Fayers PM. Quality of Life Assessment in Clinical Trials: Methods and Practice 1998, New York: Oxford University Press.
11. Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003, 60:1079-1088. 10.1001/archpsyc.60.11.1079, 14609883.